Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision tag (v3.5.4) now appears on the page, indicating a minor update to the record's metadata. The substantive study details and eligibility criteria appear unchanged.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a site/version change rather than an update to the clinical trial record itself.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.5.0 is now shown, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded a new revision entry v3.4.3 and removed the previous revision entry v3.4.2 from the revision history.SummaryDifference0.1%

- Check107 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study data or essential content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.